YUHSpace

BROWSE

YUHSpace1. College of Medicine (의과대학)BioMedical Science Institute (의생명과학부)1. Journal Papers

Browsing "1. Journal Papers" by Author : 10107

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
가 나 다 라 마 바 사 아 자 차 카 타 파 하
or enter first few letters:
  • Sort by:
  • In order:
  • Results/Page
  • Authors/Record:

Showing results 1 to 18 of 18

This table browses all dspace content
Issue DateTitleJournal Title
2022A GLP-1/GLP-2 receptor dual agonist to treat NASH: Targeting the gut-liver axis and microbiomeHEPATOLOGY
2018CB1 receptor blockade ameliorates hepatic fat infiltration and inflammation and increases Nrf2-AMPK pathway in a rat model of severely uncontrolled diabetes. PLOS ONE
2022Co-administration of ursodeoxycholic acid with rosuvastatin/ezetimibe in a non-alcoholic fatty liver disease model GASTROENTEROLOGY REPORT
2015Concerted action of p62 and Nrf2 protects cells from palmitic acid-induced lipotoxicityBIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
2020Dual roles of ULK1 (unc-51 like autophagy activating kinase 1) in cytoprotection against lipotoxicityAUTOPHAGY
2020Ezetimibe ameliorates lipid accumulation during adipogenesis by regulating the AMPK-mTORC1 pathwayFASEB JOURNAL
2016Ezetimibe, an NPC1L1 inhibitor, is a potent Nrf2 activator that protects mice from diet-induced nonalcoholic steatohepatitisFREE RADICAL BIOLOGY AND MEDICINE
2023Fecal microbiota transplantation improves hepatic fibro-inflammation via regulating oxidative stress in experimental NASH DIGESTIVE AND LIVER DISEASE
2015Fenofibrate activates Nrf2 through p62-dependent Keap1 degradationBIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
2019Implantable Vascularized Liver Chip for Cross‐Validation of Disease Treatment with Animal ModelADVANCED FUNCTIONAL MATERIALS
2019InactivationofSirtuin2protectsmicefromacetaminophen-inducedliverinjury:possibleinvolvementofERstressandS6K2activation BMB REPORTS
2016p62/SQSTM1 is required for the protection against endoplasmic reticulum stress-induced apoptotic cell deathFREE RADICAL RESEARCH
2022PERK prevents hepatic lipotoxicity by activating the p62-ULK1 axis-mediated noncanonical KEAP1-Nrf2 pathway REDOX BIOLOGY
2015PF-4708671, a specific inhibitor of p70 ribosomal S6 kinase 1, activates Nrf2 by promoting p62-dependent autophagic degradation of Keap1BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
2019Repositioningofniclosamideethanolamine(NEN), ananthelminticdrug, for thetreatmentoflipotoxicityFREE RADICAL BIOLOGY AND MEDICINE
2020SQSTM1/p62 activates NFE2L2/NRF2 via ULK1-mediated autophagic KEAP1 degradation and protects mouse liver from lipotoxicityAUTOPHAGY
2018The Antidiabetic Drug Lobeglitazone Protects Mice From Lipogenesis-Induced Liver Injury via Mechanistic Target of Rapamycin Complex 1 Inhibition. FRONTIERS IN ENDOCRINOLOGY
2017The hypertension drug, verapamil, activates Nrf2 by promoting p62-dependent autophagic Keap1 degradation and prevents acetaminophen-induced cytotoxicity BMB REPORTS
1
  • License
    sherpa_romeo
    sherpa_juliet

OAK

DSpace Software Copyright © 2002-2017 Duraspace Yonsei University Medical Library All right Reserves. / TEL:02-2228-2915 /
YUHSpace는 국립중앙도서관 OAK 보급사업으로 구축되었습니다.

Browse

Links